News
HQL
14.80
+0.07%
0.01
Equity CEFs: Top Picks For 2023
Seeking Alpha · 01/09 17:29
HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering
Seekingalpha · 12/24/2022 14:00
Tekla Life Sciences: Dividend Insights
Benzinga · 11/18/2022 15:48
Tekla Life Sciences declines quarterly dividend by -11.4% to $0.31/share
Seekingalpha · 11/16/2022 17:32
Tekla Life Sciences Investors Declares Distribution
BOSTON, November 15, 2022--On November 15, 2022, Tekla Life Sciences Investors declared a distribution of $0.31 per share. The record date for the distribution is November 25, 2022 and the payable date is December 30, 2022. The Fund will trade ex-distribut...
Business Wire · 11/15/2022 14:56
Tekla Life Sciences Investors Paid Distribution
BOSTON, September 30, 2022--On September 30, 2022, Tekla Life Sciences Investors paid a distribution of $0.31 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subs...
Business Wire · 09/30/2022 14:22
Tekla Life Sciences's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Wednesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSE:HQL).
Benzinga · 05/23/2022 15:30
Office And Retail Regain Sparkle in South Africa, Investec Says
Bloomberg · 05/18/2022 14:25
Tekla Life Sciences cuts dividend by 10% to $0.35
Tekla Life Sciences (NYSE:HQL) declares $0.35/share quarterly dividend, -10.3% decrease from prior dividend of $0.39. Forward yield 9.43% Payable June 30; for shareholders of record May 27; ex-div May 26.
Seekingalpha · 05/17/2022 15:47
--Tekla Life Sciences Cuts Quarterly Dividend to $0.35 a Share From $0.39, Payable June 30 to Shareholders as of May 27
MT Newswires · 05/17/2022 12:59
Fed’s Unwind Plan Leaves Money Markets Starved for Supply
Bloomberg · 04/06/2022 20:13
Sector Update: Financial
MT Newswires · 03/22/2022 15:44
Tekla Capital's funds extend buyback through 2023
Tekla Capital's managed funds have announced one-year extension of their stock buyback program to now expire on June. 14, 2023. It comes from Tekla Healthcare Opportunities Fund (THQ +0.6%), Tekla
Seekingalpha · 03/22/2022 14:37
Muni Strategists See Average of $470 Billion of Supply in 2022
Bloomberg · 11/24/2021 17:00
Tekla Life Sciences cuts dividend by 2%
Tekla Life Sciences (NYSE:HQL) declares $0.42/share quarterly dividend, -2.3% decrease from prior dividend of $0.43. Forward yield 8.11% Payable Dec. 31; for shareholders of record Nov. 24; ex-div Nov. 23.
Seekingalpha · 11/15/2021 15:51
Tekla World Healthcare Fund Paid Distribution
BOSTON, June 30, 2021--On June 30, 2021, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and s...
Business Wire · 06/30/2021 14:17
Tekla Healthcare Opportunities Fund Paid Distribution
On May 28, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term cap...
Business Wire · 05/28/2021 14:25
Tekla Life Sciences declares $0.41 dividend
Tekla Life Sciences (HQL) declares $0.41/share quarterly dividend, -4.7% decrease from prior dividend of $0.43.Forward yield 8.32%Payable June 30; for shareholders of record May 28; ex-div May 27.See HQL Dividend
Seekingalpha · 05/19/2021 09:51
More
Webull provides a variety of real-time HQL stock news. You can receive the latest news about Tekla Life Sciences Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQL
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.